Exclusive-Novo Nordisk India execs urge early Wegovy launch

Exclusive-Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular weight-loss drug Wegovy over fears of falling behind rival Eli Lilly in the potentially huge market,
Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 million people live with obesity.
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of rival Eli Lilly. Concerns have been raised about Novo potentially lagging behind if Wegovy is not introduced before Lilly's drug,
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms: Reuters report
In a closed-door meeting at Novo's Denmark headquarters about two months ago, the India team raised concerns that the company could lag behind Lilly in the domestic market if Wegovy was not launched early,
Novo Nordisk India execs urge early Wegovy launch as rival Eli Lilly looms
Novo and Lilly are both scaling up production as they vie for a dominant share of a weight-loss market that some analysts forecast could reach $150 billion a year in the next decade
Novo Nordisk India execs push Wegovy launch as weight-loss rival looms
Novo Nordisk’s team in India has been pushing the Danish drugmaker’s global leadership for an earlier launch of its popular weight-loss drug Wegovy over
Why your co-pay for weight loss drugs like Wegovy just went through the roof
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
STAT6h
Pharmalittle: We’re reading about menopause treatments, Novo plans for Wegovy in India, and more
Yet at the annual meeting of the Menopause Society earlier this fall, researchers presented new evidence that hormone therapy ...
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a ...
Weight loss drugs like Ozempic, Wegovy are all the rage. Are they safe for kids?
Doctors say early obesity intervention can help prevent later health problems. But prescribing GLP-1s, such as Ozempic and ...
Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk
Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk ...
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
Defiance ETFs introduces NVOX, a leveraged ETF offering 2X exposure to Novo Nordisk's stock price movements, targeting the ...
GlobalData on MSN5d
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial ...
moneycontrol.com6h
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms: Report
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its ...
The Economist5d
Wegovy hits the People’s Republic, at last
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...